IL-24 Improves Efficacy of CAR-T Cell Therapy by Targeting Stemness of Tumor Cells

The effect of CSCs on CAR-T cell therapy was determined using in vitro and in vivo assays. Subsequently, Interleukin-24 (IL-24) was expressed along with CAR in T cells.